Moderna (MRNA) news
Recent news
Moderna shares fall over 5%, Merck & Co. declines 2.2%
Moderna (MRNA) shares fell more than 5% in early trading on August 28, 2026, while Merck & Co. (MRK) declined by 2.2%. The drop follows a period of strong performance for both companies, with Merck having returned 126.6% over the past five years and Moderna experiencing a 177% surge in a single day…
AInvest Wire · 3d agoModerna shares fall over 5%, Merck & Co. declines 2.2%
Moderna (MRNA) shares fell more than 5% in early trading on August 28, 2026, while Merck & Co. (MRK) declined by 2.2%. The drop follows a period of strong performance for both companies, with Merck having returned 126.6% over the past five years and Moderna experiencing 177% surge in a single day…
AInvest Wire · 3d agoModerna: Argus research raises to buy from hold
On August 28, 2026, Argus Research upgraded its recommendation on Moderna (MRNA.US) from "Hold" to "Buy," signaling increased confidence in the company’s outlook. This move reflects a positive reassessment of Moderna’s strategic direction and potential for growth. The firm also raised its price…
AInvest Wire · 3d agoModerna buys capped calls at 175% premium to stock price
Moderna, Inc. (NASDAQ: MRNA) has announced plans to issue $2.0 billion in Convertible Senior Notes due 2032 through a private placement, with an option for initial purchasers to buy an additional $300.0 million in notes. The company will use the proceeds for general corporate purposes, including…
AInvest Wire · 3d agoModerna pricing of upsized $2.6B offering of convertible notes
AInvest Wire · 3d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.